MSL
AMRX icon

Mackay Shields LLC’s Amneal Pharmaceuticals AMRX Stock Holding History

Mackay Shields LLC’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-233,100
Closed -$904K – 1493
2020
Q3 		$904K Buy
+233,100
New +$997K 0.01% 1051
2020
Q1 		– Sell
-785,200
Closed -$3.78M – 1390
2019
Q4 		$3.78M Buy
+785,200
New +$2.73M 0.03% 589

Other funds holding AMRX

FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Mackay Shields LLC's AMRX Position: Q4 2020 in Review

Mackay Shields LLC sold out of Amneal Pharmaceuticals (AMRX) in Q4 2020, closing a stake of 233,100 shares — an estimated $904K sold.

Mackay Shields LLC first reported a position in AMRX in Q4 2019 and held it in 2 quarters. The position peaked at $3.78M in Q4 2019. 133 funds tracked by Wall St. Rank hold AMRX as of Q4 2020.

  • Mackay Shields LLC reported no remaining Amneal Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Mackay Shields LLC sold 233,100 Amneal Pharmaceuticals shares in Q4 2020, an estimated $904K.
  • Mackay Shields LLC first reported a position in Amneal Pharmaceuticals in Q4 2019 and held it in 2 quarters.
  • Mackay Shields LLC's Amneal Pharmaceuticals position peaked at $3.78M in Q4 2019.
  • 133 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2020.

Based on Mackay Shields LLC's 13F filing for Q4 2020, filed 16 Feb 2021.